Replication data for: The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation

Principal Investigator(s): View help for Principal Investigator(s) Guy David; Sara Markowitz; Seth Richards-Shubik

Name	File Type	Size	Last Modified
AEJPol-2009-0070_data.dta	application/octet-stream	71.7 KB	08/03/2019 06:44:AM
AEJPol-2009-0070_readme.pdf	application/pdf	58.2 KB	08/03/2019 06:44:AM
AEJPol-2009-0070_tables.do	text/plain	17.7 KB	08/03/2019 06:44:AM
LICENSE.txt	text/plain	14.6 KB	08/03/2019 06:44:AM

Project Citation:

Project Description

Summary: This paper analyzes the relationship between postmarketing promotional activity and reporting of adverse drug reactions (ADRs) by modeling the interaction between a regulator (the FDA) and a pharmaceutical firm. Promotion-driven market expansions enhance profitability yet may involve the risk of inappropriate drug prescriptions, leading to regulatory actions against the firm. We empirically test the relationship between drug promotion and reporting of ADRs using an innovative combination of commercial data on pharmaceutical promotion and FDA data on regulatory interventions and ADRs. We provide some evidence that increased levels of promotion and advertising lead to increased reporting of ADRs for certain conditions. (JEL L51, L65, M31, M37)

Scope of Project

JEL Classification:
      M31 Marketing
      M37 Advertising
      L65 Chemicals • Rubber • Drugs • Biotechnology • Plastics
      L51 Economics of Regulation

Related Publications

Download this project

Published Versions

V1 [2019-08-03]

Export Metadata

Dublin Core

DDI 2.5

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as received from the data depositor. As of April 2026, depositors are required to submit study materials in accessible formats. ICPSR has not reviewed, checked, or processed this material. For additional information about the study, please contact the investigator(s) directly. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR's Accessibility Center.